Induction chemotherapy for nasopharyngeal carcinoma is a kind of neoadjuvant chemotherapy, which is mainly carried out before radiotherapy, and plays a role in shrinking the tumor volume and protecting the endangered organs. The specific chemotherapy program needs to be chosen according to the specific condition. When induction chemotherapy is carried out before radiotherapy, the local blood vessels of the tumor have not yet formed fibrosis, and the chemotherapeutic drugs can easily reach the required concentration in the tissues, so it can effectively reduce the size of the tumor, reduce the dose of subsequent radiotherapy irradiation, increase the sensitivity of radiotherapy, and remove the tiny metastatic foci that may exist in the bloodstream or in the distant places, so as to reduce the probability of distant metastasis of the tumor. Induction chemotherapy commonly used drugs need to be under the guidance of a doctor, and any adverse reactions in the process of drug use need to be timely consultation and treatment. Commonly used drugs include paclitaxel, cisplatin, 5-fluorouracil, gemcitabine and so on. The specific combination of drugs, induction chemotherapy time and duration of treatment need to be individualized, and it is recommended that the people concerned should seek medical advice and treatment in a timely manner.